Μηλάκη Γεωργία

Σπουδές

• Υποψήφια Διδάκτωρ, Ιατρική Σχολή, Πανεπιστήμιο Κρήτης
• Πτυχίο Ιατρικής, Ιατρική Σχολή, Πανεπιστήμιο της Νάπολης, Ιταλία (1999)
• Ειδίκευση στον Καρκίνο του Μαστού, Διεθνές Ευρωπαϊκό Κέντρο του Καρκίνου
• Ειδικότητα Ογκολογίας, Πανεπιστημιακό Γενικό Νοσοκομείο Ηρακλείου (2010)

Επαγγελματική εμπειρία

• Ιδιωτικό ιατρείο, Ηράκλειο Κρήτης (2015 - σήμερα)
• Επιμελήτρια, Ογκολογικό Τμήμα, Γενικό Νοσοκομείο Ηρακλείου "Βενιζέλειο" (2011 - 2015)
• Συνεργάτις Ιατρός, Ασκληπιείον Κρήτης
• Συνεργάτις Ιατρός, Creta InterClinic
• Αγροτικός Ιατρός, Περιφερειακό Ιατρείο Μαλίων - Κέντρο Υγείας Καστελλίου, Κρήτη

Μέλος συλλόγων

• Εταιρεία Ογκολόγων Παθολόγων Ελλάδος (ΕΟΠΕ)
• Ευρωπαϊκή Ογκολογική Εταιρεία (ESMO)
• Αμερικανική Ογκολογική Εταιρεία (ASCO)

Δημοσιεύσεις

• SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer Balgkouranidou I, Chimonidou M, Milaki G, Tsaroucha E, Kakolyris S, Georgoulias V, Lianidou E. Clin Chem Lab Med. 2016 Aug 1;54(8):1385-9 (2016)
• Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG). Bamias A, Peroukidis S, Stamatopoulou S, Tzannis K, Koutsoukos K, Andreadis C, Bozionelou V, Pistalmatzian N, Papatsoris A, Stravodimos K, Varthalitis I, Karamouzis M, Milaki G, Agorastos A, Kentepozidis N, Androulakis N, Bompolaki I, Kalofonos H, Mavroudis D, Dimopoulos MA. Clin Genitourin Cancer. 2016 Apr;14(2):e153-9 (2016)
• Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group. Pistamaltzian N, Tzannis K, Pissanidou V, Peroukidis S, Milaki G, Karavasilis V, Mitsogiannis I, Varkarakis I, Papatsoris A, Dellis A, Adamakis I, Stravodimos K, Molyva D, Athanasiadis I, Androulakis N, Andreadis C, Kalofonos C, Mitropoulos D, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A. Anticancer Drugs. 2016 Jan;27(1):48-53 (2016)
• Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR, Georgoulias V, Lianidou ES. Br J Cancer. 2014 Apr 15;110(8):2054-62 (2014)
• Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer. Saloustros E, Kalbakis K, Vardakis N, Kalykaki A, Milaki G, Rovithi M, Agelaki S, Saridaki Z, Georgoulias V, Mavroudis D.J BUON. 2011 Apr-Jun;16(2):215-8 (2011)
• A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract. Karachaliou N, Polyzos A, Kentepozidis N, Kakolyris S, Ziras N, Vardakis N, Kalykaki A, Milaki G, Georgoulias V, Androulakis N. Oncology. 2010;78(5-6):356-60 (2010)
• Idiopathic CD4+ T lymphocytopenia disclosed by recurrent cryptococcal meningitis. First case report from Greece. Kofteridis DP, Saridaki Z, Kazakou I, Lazaridou S, Alegakis D, Milaki G, Gikas A. Int J Infect Dis. 2005 Nov;9(6):347-8. Epub 2005 Oct 17 (2005)
• Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.Souglakos J, Pallis A, Kakolyris S, Mavroudis D, Androulakis N, Kouroussis C, Agelaki S, Xenidis N, Milaki G, Georgoulias V. Oncology. 2005;69(5):384-90 (2005)
• Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study. Mavroudis D, Malamos N, Polyzos A, Kouroussis Ch, Christophilakis Ch, Varthalitis I, Androulakis N, Kalbakis K, Milaki G, Georgoulias V; Breast Cancer Study Group of the Hellenic Oncology Research Group (HORG). Oncology. 2004;67(3-4):250-6 (2004)
• A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer. Agelaki S, Syrigos K, Christophylakis C, Boukovinas J, Varthalitis J, Pavlakou G, Athanasiadis A, Kouroussis C, Vardakis N, Maltezakis G, Milaki G, Georgoulias V; Lung Cancer Subgroup, Hellenic Oncology Research Group. Oncology. 2004;66(3):192-6 (2004)
• A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer. Agelaki S, Veslemes M, Syrigos K, Palamidas F, Polyzos A, Papakotoulas P, Kentepozidis N, Milaki G, Tzanakis N, Kouroussis C, Vamvakas L, Georgoulias V; Hellenic Oncology Research Group. Lung Cancer. 2004 Mar;43(3):329-33 (2004)
• περισσότερα